Despite PSA screening and the control by radical prostatectomy, patients treatment fails and have a PSA recurrence.
Lotan
Yair
Y
Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX 75309-9110, USA. Yair.Lotan@UTSouthwestern.edu
D000368:Aged; D000369:Aged, 80 and over; D000726:Androgen Antagonists / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D049451:Nomograms; D011237:Predictive Value of Tests; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D015996:Survival Rate; D017211:Treatment Failure
D000726:Androgen Antagonists; D017430:Prostate-Specific Antigen